PT  - JOURNAL ARTICLE
AU  - Liu, Lun
AU  - Wang, Hui
AU  - Zhang, Zhu
AU  - Zhang, Weiyi
AU  - Zhuang, Shengsheng
AU  - Lv, Tingmiao
AU  - Chio, Chi On
AU  - Wang, Yifan
AU  - Na, Daori
AU  - Tang, Chuchang
AU  - Ao-Ieong, On Ieng
TI  - Infectiousness of places: The impact of human settlement and activity space in the transmission of COVID-19
AID  - 10.1101/2021.09.02.21263012
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.02.21263012
4099  - http://medrxiv.org/content/early/2021/09/07/2021.09.02.21263012.short
4100  - http://medrxiv.org/content/early/2021/09/07/2021.09.02.21263012.full
AB  - Places are fundamental factors in the spread of epidemics, as they are where people agglomerate and interact. This paper explores how different types of places—activity spaces at micro-level and human settlements at macro-level—impact the transmission of infections using evidences from COVID-19. We examine eleven types of activity spaces and find heterogeneous impacts across countries, yet we also find that non-essential activity spaces tend to have larger impacts than essential ones. Contrary to common beliefs, settlement size and density are not positively associated with reproduction numbers. Further, the impacts of closing activity spaces vary with settlement types and are consistently lower in larger settlements in all sample countries, suggesting more complex pattern of virus transmission in large settlements. This work takes first steps in systematically evaluating the epistemological risks of places at multiple scales, which contributes to knowledge in urban resilience, health and livability.Teaser Activity spaces and human settlement characteristics impact the spread of epidemics in multiple ways and should be considered in policy making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBeijing Social Science Foundation 20GLA003 (LL) National Natural Science Foundation of China 52008005 (LL) Institute of Public Governance, Peking University YQZX202005 (LL) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data are available on the following Github repository: https://github.com/lunliu454/infect_place. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. https://github.com/lunliu454/infect_place